2020 ASCO Virtual Direct™ Highlights


 

PARPi Efficacy in Recurrent Platinum Sensitive Ovarian Cancer: Is Olaparib More Effective as Mono or Combination Therapy?

128 views
October 13, 2020
Comments 0
Login to view comments. Click here to Login